Earnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Decline

The market expects ADC Therapeutics SA (ADCT) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, ...